These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 3116918

  • 41. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000].
    Nakasone I, Onaga S, Fukunaga H, Saitoh H, Yamane N, Sato Y.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
    Isaksson B, Hanberger H, Maller R, Nilsson LE, Nilsson M.
    Scand J Infect Dis Suppl; 1990 Sep; 74():129-32. PubMed ID: 2129064
    [Abstract] [Full Text] [Related]

  • 46. Amikacin, ceftazidime, and flucloxacillin against suspended and adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an in vitro model of infection.
    Vergères P, Blaser J.
    J Infect Dis; 1992 Feb; 165(2):281-9. PubMed ID: 1730894
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004.
    Lee K, Lim CH, Cho JH, Lee WG, Uh Y, Kim HJ, Yong D, Chong Y, KONSAR Group.
    Yonsei Med J; 2006 Oct 31; 47(5):634-45. PubMed ID: 17066507
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    Pechère JC, Marchou B, Michéa-Hamzehpour M, Auckenthaler R.
    J Antimicrob Chemother; 1986 Mar 31; 17 Suppl A():11-8. PubMed ID: 3086276
    [Abstract] [Full Text] [Related]

  • 56. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H.
    Molecules; 2016 Jan 06; 21(1):62. PubMed ID: 26751436
    [Abstract] [Full Text] [Related]

  • 57. The postantibiotic effect of meropenem and imipenem on selected bacteria.
    Nadler HL, Pitkin DH, Sheikh W.
    J Antimicrob Chemother; 1989 Sep 06; 24 Suppl A():225-31. PubMed ID: 2509416
    [Abstract] [Full Text] [Related]

  • 58. [In vitro activity of ciprofloxacin against multiresistant microorganisms isolated from cases of hospital infection].
    Caiaffa Filho HH, Mendes CM.
    AMB Rev Assoc Med Bras; 1987 Sep 06; 33(5-6):99-102. PubMed ID: 3129763
    [No Abstract] [Full Text] [Related]

  • 59. [Common pathogens in burn infection and changes in their drug sensitivity].
    Zhang YP.
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1991 Jun 06; 7(2):108-10, 157-8. PubMed ID: 1773380
    [Abstract] [Full Text] [Related]

  • 60. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.
    Tsui SY, Yew WW, Li MS, Chan CY, Cheng AF.
    Antimicrob Agents Chemother; 1993 May 06; 37(5):1001-3. PubMed ID: 8517688
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.